Universität Leipzig
Leipzig 04203
3 studies enrolling now · 10 studies all time
What they study most
Alzheimers Disease, Atherosclerosis of Native Arteries of the Extremities, Focal Segmental Glomerulosclerosis, Head and Neck Squamous Cell Carcinoma, Idiopathic Pulmonary Fibrosis, Multiple Sclerosis, Myelofibrosis, Peripheral Arterial Disease, Solid Tumours
Studies at this site
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
- Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations — Recruiting now
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
- A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) — Running, not enrolling
- A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone — Running, not enrolling
- The DETOUR 2 Clinical Trial — Completed
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis — Running, not enrolling
- ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent — Completed